Kenneth W O'Keefe

JAZZ

Kenneth W O'Keefe serves as Director at Jazz Pharmaceuticals plc (JAZZ). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$305.2K

Net Position

Net Seller

$305.2K

Companies Traded

JAZZ

Active Period

Aug 2025 – Dec 2025

2 total trades

Most Recent

Sell JAZZ

Dec 2, 2025 · $104.4K

Kenneth W O'Keefe's Insider Trading at Jazz Pharmaceuticals plc (JAZZ)

Buys

0 · $0.00

Sells

2 · $305.2K

Total Shares Bought

Total Shares Sold

2,408

JAZZ Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 2, 2025	Sell	603	$173.07	$104.4K	0
Aug 7, 2025	Sell	1,805	$111.25	$200.8K	0

Related Insiders

Neena M Patil

EVP & Chief Legal Officer

JAZZSell · Jan 16, 2026

COZADD BRUCE C

Director

JAZZSell · Jan 16, 2026

GALA RENEE D

President & CEO

JAZZSell · Jan 16, 2026

Robert Iannone

EVP, Global Head of R&D & CMO

JAZZSell · Jan 16, 2026

Samantha Pearce

EVP, Chief Commercial Officer

JAZZSell · Jan 16, 2026

Mary Elizabeth Henderson

SVP, Technical Operations

JAZZSell · Dec 9, 2025

Patricia Carr

SVP, Chief Accounting Officer

JAZZSell · Dec 5, 2025

Heather Ann McSharry

Director

JAZZSell · Nov 20, 2025

Explore More Insider Trading Data

JAZZ Insider Trading Activity

View all insider trades at Jazz Pharmaceuticals plc

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity